Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Risperidone plasma levels, clinical response and side-effects.

Michael Riedel1, M J Schwarz, M Strassnig

  • 1Dept. of Psychiatry and Psychotherapy, University of Munich, 80336 Munich, Germany. Riedel@med.uni-muenchen.de

European Archives of Psychiatry and Clinical Neuroscience
|November 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Non-Response to Antidepressants: Risk Factors and Therapeutic Possibilities.

Pharmacopsychiatry·2026
Same author

Vagal Nerve Stimulation-Modulation of the Anti-Inflammatory Response and Clinical Outcome in Psoriatic Arthritis or Ankylosing Spondylitis.

Mediators of inflammation·2021
Same author

The role of interleukin-18 in the diagnosis and monitoring of hemophagocytic lymphohistiocytosis/macrophage activation syndrome - a systematic review.

Clinical and experimental immunology·2020
Same author

Short-term transcutaneous non-invasive vagus nerve stimulation may reduce disease activity and pro-inflammatory cytokines in rheumatoid arthritis: results of a pilot study.

Scandinavian journal of rheumatology·2020
Same author

π/2 mode converters and vortex generators for electrons.

Ultramicroscopy·2019
Same author

Soluble CD163 and soluble mannose receptor predict survival and decompensation in patients with liver cirrhosis, and correlate with gut permeability and bacterial translocation.

Alimentary pharmacology & therapeutics·2017
Same journal

Abnormal emotional intensity processing in individuals at clinical high risk for psychosis: evidence from event-related potentials.

European archives of psychiatry and clinical neuroscience·2026
Same journal

The role of attention in perceptual biases in patients with schizophrenia spectrum disorder and healthy controls.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Effects of quetiapine on cognitive functioning in schizophrenia: evidence for the remyelination hypothesis?

European archives of psychiatry and clinical neuroscience·2026
Same journal

Effects of xanomeline-trospium on the gut-lung microbiota axis and susceptibility to LPS-induced acute lung injury in male and female mice.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Association of the red blood cell distribution width-to-albumin ratio with incident depression and depressive symptom trajectories in older adults.

European archives of psychiatry and clinical neuroscience·2026
Same journal

Major depressive disorder-alcohol use disorder comorbidity: diagnosis, mechanisms and treatment.

European archives of psychiatry and clinical neuroscience·2026
See all related articles

Schizophrenia patients responding to risperidone had lower drug levels than non-responders, despite similar oral doses. Monitoring risperidone and 9-OH-risperidone levels is crucial for effective treatment and managing side effects.

Area of Science:

  • Pharmacology
  • Psychiatry
  • Genetics

Background:

  • Risperidone metabolism varies due to CYP2D6 genetic differences, impacting drug levels and treatment outcomes.
  • Understanding the relationship between risperidone dose, serum levels, and clinical response is key for optimizing schizophrenia treatment.

Purpose of the Study:

  • To investigate the correlation between oral risperidone dose, serum concentrations, clinical efficacy, and side effects.
  • To determine the influence of CYP2D6 genetic polymorphisms on risperidone plasma levels and treatment response.

Main Methods:

  • A 6-week open-label trial involving schizophrenia patients receiving risperidone monotherapy.
  • Weekly assessments of psychopathology (CGI, PANSS), side effects (SAS), and plasma levels of risperidone and 9-OH-risperidone.

Related Experiment Videos

  • Genotyping of major CYP2D6 polymorphisms (*4, *6, *14).

    • Main Results:

    • Responders exhibited significantly lower active moiety plasma levels compared to non-responders, despite similar oral doses.
    • Higher plasma levels at week 2 predicted extrapyramidal side effects (EPS).
    • CYP2D6 polymorphisms did not predict clinical response but showed a trend in altering the risperidone to 9-OH-risperidone ratio.

    Conclusions:

    • Lower serum concentrations of risperidone and 9-OH-risperidone are associated with better treatment response in schizophrenia.
    • Plasma level monitoring of risperidone and 9-OH-risperidone is recommended due to high inter-individual variability.
    • Careful dose titration is necessary to minimize the risk of EPS, especially at higher initial doses.